Spartan Fund Management’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$295K Buy
+25,264
New +$293K 0.98% 25
2024
Q1
Sell
-118,423
Closed -$1.3M 131
2023
Q4
$1.3M Buy
+118,423
New +$1.29M 1.59% 24
2023
Q2
Sell
-62,671
Closed -$657K 355
2023
Q1
$657K Hold
62,671
0.31% 108
2022
Q4
$643K Sell
62,671
-75,516
-55% -$766K 0.23% 142
2022
Q3
$1.38M Buy
+138,187
New +$1.39M 0.42% 96

Other funds holding RENE

Spartan Fund Management's RENE Position: Q4 2024 in Review

Spartan Fund Management opened a new position in Cartesian Growth Corp II (RENE) in Q4 2024: 25,264 shares worth $295K. The stake represents 0.98% of the portfolio and ranks #25 among its holdings. This is a return to the name: Spartan Fund Management previously reported a position in RENE as recently as Q4 2023.

Spartan Fund Management first reported a position in RENE in Q3 2022 and has held it in 5 quarters since. The position peaked at $1.38M in Q3 2022. 19 funds tracked by Wall St. Rank hold RENE as of Q4 2024.

  • Spartan Fund Management held 25,264 shares of Cartesian Growth Corp II worth $295K as of Q4 2024.
  • Cartesian Growth Corp II was a new Spartan Fund Management position in Q4 2024.
  • Cartesian Growth Corp II made up 0.98% of Spartan Fund Management's portfolio in Q4 2024, its #25 holding.
  • Spartan Fund Management first reported a position in Cartesian Growth Corp II in Q3 2022 and has held it in 5 quarters since.
  • Spartan Fund Management's Cartesian Growth Corp II position peaked at $1.38M in Q3 2022.
  • 19 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2024.

Based on Spartan Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.